| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/13/2023 | 10.48% | Morgan Stanley | $20 → $18.5 | Maintains | Equal-Weight |
| 10/06/2023 | 25.41% | HC Wainwright & Co. | $22 → $21 | Reiterates | Buy → Buy |
| 10/03/2023 | 19.44% | Evercore ISI Group | → $20 | Reinstates | → Outperform |
| 08/04/2023 | 31.38% | HC Wainwright & Co. | → $22 | Reiterates | Buy → Buy |
| 08/03/2023 | 19.44% | Morgan Stanley | $20 → $20 | Reiterates | Equal-Weight → Equal-Weight |
| 08/03/2023 | 13.47% | Barclays | $18 → $19 | Maintains | Equal-Weight |
| 07/24/2023 | 25.41% | RBC Capital | $20 → $21 | Maintains | Outperform |
| 07/10/2023 | 37.35% | Citigroup | $22 → $23 | Maintains | Buy |
| 07/03/2023 | 37.35% | B of A Securities | $19 → $23 | Maintains | Buy |
| 07/03/2023 | 31.38% | HC Wainwright & Co. | → $22 | Reiterates | Buy → Buy |
| 05/30/2023 | 19.44% | Morgan Stanley | → $20 | Assumes | → Equal-Weight |
| 05/19/2023 | 31.38% | HC Wainwright & Co. | $19 → $22 | Maintains | Buy |
| 05/05/2023 | 13.47% | HC Wainwright & Co. | $21 → $19 | Maintains | Buy |
| 05/05/2023 | 7.49% | Barclays | $17 → $18 | Maintains | Equal-Weight |
| 05/04/2023 | 19.44% | RBC Capital | → $20 | Reiterates | → Outperform |
| 03/23/2023 | 25.41% | HC Wainwright & Co. | → $21 | Reiterates | → Buy |
| 03/09/2023 | — | Needham | Initiates Coverage On | → Hold | |
| 02/24/2023 | 25.41% | HC Wainwright & Co. | $20 → $21 | Maintains | Buy |
| 02/23/2023 | 1.52% | JP Morgan | $15 → $17 | Maintains | Neutral |
| 02/23/2023 | 19.44% | Morgan Stanley | $18 → $20 | Maintains | Equal-Weight |
| 02/23/2023 | 19.44% | RBC Capital | → $20 | Reiterates | → Outperform |
| 02/15/2023 | 19.44% | RBC Capital | $17 → $20 | Maintains | Outperform |
| 02/02/2023 | 19.44% | HC Wainwright & Co. | → $20 | Reiterates | → Buy |
| 12/21/2022 | 1.52% | Barclays | → $17 | Initiates Coverage On | → Equal-Weight |
| 11/23/2022 | 1.52% | Goldman Sachs | $19 → $17 | Maintains | Neutral |
| 11/03/2022 | -10.42% | JP Morgan | $16 → $15 | Maintains | Neutral |
| 11/03/2022 | 1.52% | RBC Capital | $18 → $17 | Maintains | Outperform |
| 11/03/2022 | 7.49% | Morgan Stanley | $19 → $18 | Maintains | Equal-Weight |
| 11/03/2022 | 19.44% | HC Wainwright & Co. | $21 → $20 | Maintains | Buy |
| 10/11/2022 | 13.47% | Morgan Stanley | $20 → $19 | Maintains | Equal-Weight |
| 09/12/2022 | 25.41% | HC Wainwright & Co. | → $21 | Initiates Coverage On | → Buy |
| 08/16/2022 | 13.47% | Goldman Sachs | $22 → $19 | Maintains | Neutral |
| 07/26/2022 | 31.38% | RBC Capital | → $22 | Initiates Coverage On | → Outperform |
| 06/24/2022 | 25.41% | Evercore ISI Group | → $21 | Initiates Coverage On | → Outperform |
| 06/09/2022 | 19.44% | Morgan Stanley | $22 → $20 | Maintains | Equal-Weight |
| 06/06/2022 | 31.38% | Citigroup | → $22 | Initiates Coverage On | → Buy |
| 05/31/2022 | 31.38% | Morgan Stanley | → $22 | Initiates Coverage On | → Equal-Weight |
| 05/31/2022 | 31.38% | Goldman Sachs | → $22 | Initiates Coverage On | → Neutral |
| 05/31/2022 | 43.33% | Guggenheim | → $24 | Initiates Coverage On | → Buy |
| 05/31/2022 | 37.35% | Wells Fargo | → $23 | Initiates Coverage On | → Overweight |
| 05/11/2022 | 109.02% | Cowen & Co. | → $35 | Initiates Coverage On | → Outperform |
What is the target price for Bausch & Lomb (BLCO)?
The latest price target for Bausch & Lomb (NYSE: BLCO) was reported by Morgan Stanley on October 13, 2023. The analyst firm set a price target for $18.50 expecting BLCO to rise to within 12 months (a possible 10.48% upside). 29 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Bausch & Lomb (BLCO)?
The latest analyst rating for Bausch & Lomb (NYSE: BLCO) was provided by Morgan Stanley, and Bausch & Lomb maintained their equal-weight rating.
When is the next analyst rating going to be posted or updated for Bausch & Lomb (BLCO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bausch & Lomb, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bausch & Lomb was filed on October 13, 2023 so you should expect the next rating to be made available sometime around October 13, 2024.
Is the Analyst Rating Bausch & Lomb (BLCO) correct?
While ratings are subjective and will change, the latest Bausch & Lomb (BLCO) rating was a maintained with a price target of $20.00 to $18.50. The current price Bausch & Lomb (BLCO) is trading at is $16.75, which is out of the analyst's predicted range.